BlackRock Institutional Trust’s Kite Pharma, Inc. KITE Stock Holding History

BlackRock Institutional Trust’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$51.7M	Buy	1,153,353 +94,354	+9%	+$4.63M	0.01%	1327
2016 Q3	$59.2M	Buy	1,058,999 +41,115	+4%	+$2.29M	0.01%	1179
2016 Q2	$50.9M	Buy	1,017,884 +60,981	+6%	+$3M	0.01%	1227
2016 Q1	$43.9M	Buy	956,903 +62,968	+7%	+$3.05M	0.01%	1310
2015 Q4	$55.1M	Buy	893,935 +96,436	+12%	+$6.79M	0.01%	1181
2015 Q3	$44.4M	Buy	797,499 +352,073	+79%	+$22.1M	0.01%	1295
2015 Q2	$27.2M	Buy	445,426 +138,105	+45%	+$7.88M	﹤0.01%	1708
2015 Q1	$17.7M	Buy	307,321 +71,823	+30%	+$4.81M	﹤0.01%	2028
2014 Q4	$13.6M	Buy	235,498 +163,824	+229%	+$6.9M	﹤0.01%	2172
2014 Q3	$2.04M	Buy	+71,674	New	+$1.77M	﹤0.01%	3070

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BlackRock Institutional Trust's KITE Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Kite Pharma, Inc. (KITE) stake by 8.9% in Q4 2016, buying an estimated $4.63M and bringing the position to 1,153,353 shares worth $51.7M. The position accounts for 0.01% of the portfolio, ranked #1327.

BlackRock Institutional Trust first reported a position in KITE in Q3 2014 and has held it in 10 quarters since. The position peaked at $59.2M in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

BlackRock Institutional Trust held 1,153,353 shares of Kite Pharma, Inc. worth $51.7M as of Q4 2016.
BlackRock Institutional Trust bought 94,354 Kite Pharma, Inc. shares in Q4 2016, an estimated $4.63M.
Kite Pharma, Inc. made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1327 holding.
BlackRock Institutional Trust first reported a position in Kite Pharma, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Kite Pharma, Inc. position peaked at $59.2M in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.